Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, mu... by Yun Liu, Maolan Li, Fatao Liu, Yingbin Liu, Yongsheng Li, Xu-An Wang, Wenguang Wu, Mao Yang, Yuhao Zhao, Xuya Cui

Get full text

Targeted therapies and immunotherapies for unresectable cholangiocarcinoma by Shengbai Xue, Weihua Jiang, Jingyu Ma, Haiyan Xu, Yanling Wang, Wenxin Lu, Daiyuan Shentu, Jiujie Cui, Maolan Li, Liwei Wang, Xiangxiang Pan

Get full text

Disease burden of biliary tract cancer in 204 countries and territories, 1990–2021: A comprehensive demographic analysis of the Global Burden of Disease Study 2021 by Xuheng Sun, Jiangmei Liu, Wei Zhang, Yijun Wang, Yan Jiang, Lijun Wang, Yixin Zou, Yuxuan Xiao, Yongbing Xiang, Maolan Li, Maigeng Zhou, Yingbin Liu, Sihan Zhou, Xiuyuan Hao

Get full text

Full-length transcriptome atlas of gallbladder cancer reveals trastuzumab resistance conferred by ERBB2 alternative splicing by Ziyi Wang, Li Gao, Ziheng Jia, Liguo Liu, Ao Gu, Zhaonan Liu, Qin Zhu, Yichen Zuo, Mingjie Yang, Shijia Wang, Jiyao Ma, Jingyun Zhang, Shimei Qiu, Zhizhen Li, Jinghan Wang, Dongxi Xiang, Fatao Liu, Rong Shao, Yanjing Li, Maolan Li, Wu Wei, Yingbin Liu

Get full text

Super‐Enhancer Reprograming Driven by SOX9 and TCF7L2 Represents Transcription‐Targeted Therapeutic Vulnerability for Treating Gallbladder Cancer by Siyuan Yan, Zhaonan Liu, Teng Wang, Yi Sui, Xiangsong Wu, Jiayi Shen, Peng Pu, Yang Yang, Sizhong Wu, Shimei Qiu, Ziyi Wang, Xiaoqing Jiang, Feiling Feng, Guoqiang Li, FaTao Liu, Chaoxian Zhao, Ke Liu, Jiayi Feng, Maolan Li, Kwan Man, Chaochen Wang, Yujie Tang, Yingbin Liu

Get full text